These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 24231296)

  • 21. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study.
    Rouprêt M; Drouin SJ; Larré S; Neuzillet Y; Botto H; Hitier M; Rigaud J; Crew J; Xylinas E; Salomon L; Cornu JN; Iborra F; Champetier D; Rozet F; Flamand V; Bastide C; Cormier L; Durand X; Lunardi P; Rischmann P; Nouhaud FX; Ferlicot S; Patard JJ; Floch AP; Irani J; Peyronnet B; Bensalah K; Poissonnier L; Grès P; Droupy S; Casenave J; Wallerand H; Soulié M; Pfister C;
    Ann Surg Oncol; 2011 Dec; 18(13):3833-8. PubMed ID: 21647762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
    J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
    J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
    Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
    BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience.
    Kassouf W; Spiess PE; Siefker-Radtke A; Swanson D; Grossman HB; Kamat AM; Munsell MF; Guo CC; Czerniak BA; Dinney CP
    Cancer; 2007 Aug; 110(4):764-9. PubMed ID: 17614317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
    BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer.
    Djaladat H; Bruins HM; Miranda G; Cai J; Skinner EC; Daneshmand S
    J Urol; 2012 Dec; 188(6):2134-8. PubMed ID: 23083874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
    Kassouf W; Agarwal PK; Herr HW; Munsell MF; Spiess PE; Brown GA; Pisters L; Grossman HB; Dinney CP; Kamat AM
    J Clin Oncol; 2008 Jan; 26(1):121-6. PubMed ID: 18165646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder.
    Daneshmand S; Stein JP; Lesser T; Quek ML; Nichols PW; Miranda G; Cai J; Groshen S; Skinner EC; Skinner DG
    J Urol; 2004 Jul; 172(1):81-4. PubMed ID: 15201742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.
    Tilki D; Svatek RS; Novara G; Seitz M; Godoy G; Karakiewicz PI; Kassouf W; Fradet Y; Fritsche HM; Sonpavde G; Izawa JI; Ficarra V; Lerner SP; Schoenberg M; Stief CG; Dinney CP; Skinner E; Lotan Y; Sagalowsky AI; Reich O; Shariat SF
    J Urol; 2010 Sep; 184(3):888-94. PubMed ID: 20643448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
    Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Lotan Y; Vazina A; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP;
    J Urol; 2006 May; 175(5):1645-9; discussion 1649. PubMed ID: 16600721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radical cystectomy for primary bladder malignancy: a 10 year review.
    Louie-Johnsun MW; Braslis KG; Murphy DL; Neerhut GJ; Grills RJ
    ANZ J Surg; 2007 Apr; 77(4):265-9. PubMed ID: 17388833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.